Datamonitor, Sep 2010, Pages: 204
effective therapies are needed for the treatment of advanced disease
Research efforts should be directed towards the development of predictive markers and molecular targeted therapy
New product development
Panel Intelligence, LLC, Oct 2004
In 2003, approximately 40,000 deaths in the United States were attributed to breast cancer. While significant therapeutic advances for early-stage disease have emerged in recent years, an estimated
GBI Research, March 2011, Pages: 194
Market Is Backed By Strong R&D Activity 62
8.5 R&D Trends 65
8.5.1 Discovery of Unknown Mutations that Play Key Role in Cancers 65
8.5.2 Pairing Therapeutics and Diagnostics 66
8.6 Key Late Stage Pipeline Drugs 67
8
Datamonitor, Nov 2008, Pages: 362
by disease stage at presentation and proportion receiving anti-cancer therapy
- In-depth analysis of treatment patterns, regimens prescribed and treatment outcomes for CLL and CML by line of therapy
